| Unraveling the therapeutic potential of natural products in the prevention and treatment of leukemia H Goel, R Kumar, P Tanwar, TK Upadhyay, F Khan, P Pandey, S Kang, ... Biomedicine & Pharmacotherapy 160, 114351, 2023 | 13 | 2023 |
| Structural and conformational changes induced by missense variants in the zinc finger domains of GATA3 involved in breast cancer R Kumar, R Kumar, P Tanwar, SVS Deo, S Mathur, U Agarwal, S Hussain RSC advances 10 (65), 39640-39653, 2020 | 8 | 2020 |
| Computational investigation reveals that the mutant strains of SARS-CoV2 have differential structural and binding properties R Kumar, R Kumar, H Goel, P Tanwar Computer Methods and Programs in Biomedicine 215, 106594, 2022 | 7 | 2022 |
| Deciphering the impact of missense mutations on structure and dynamics of SMAD4 protein involved in pathogenesis of gall bladder cancer R Kumar, R Kumar, P Tanwar, GK Rath, R Kumar, S Kumar, N Dash, ... Journal of Biomolecular Structure and Dynamics, 1-15, 2020 | 7 | 2020 |
| Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma S Kumar, N Nadda, A Quadri, R Kumar, S Paul, P Tanwar, S Gamanagatti, ... Frontiers in Genetics 14, 1235260, 2023 | 5 | 2023 |
| Presence of entry receptors and viral markers suggest a low level of placental replication of hepatitis B virus in a proportion of pregnant women infected with chronic hepatitis B G Garg, MN Meenu, K Patel, R Singh, P Gupta, S Purwar, ... Scientific Reports 12 (1), 17795, 2022 | 4 | 2022 |
| Comprehensive mutations analyses of FTO (fat mass and obesity-associated gene) and their effects on FTO’s substrate binding implicated in obesity R Kumar, SS Ningombam, R Kumar, H Goel, A Gogia, S Khurana, ... Frontiers in Nutrition 9, 852944, 2022 | 4 | 2022 |
| In silico drug designing for COVID-19: an approach of high-throughput virtual screening, molecular, and essential dynamics simulations R Kumar, R Kumar, P Tanwar Journal of Biomolecular Structure and Dynamics 40 (16), 7394-7407, 2022 | 1 | 2022 |
| Comprehensive mutation profiling of PIK3CA gene in Indian breast cancer patients R Kumar, U Agrawal, S Deo, SR Mathur, A Gogia, P Tanwar European Journal of Cancer 175, S33, 2022 | 1 | 2022 |
| Computational Drug Discovery and Development Along With Their Applications in the Treatment of Women-Associated Cancers R Kumar, R Kumar, H Goel, SS Ningombam, P Tanwar Latest Advances in Diagnosis and Treatment of Women-Associated Cancers, 13, 2022 | 1 | 2022 |
| Structural based screening of potential inhibitors of SMAD4: a step towards personalized medicine for gall bladder and other associated cancers R Kumar, R Kumar, P Tanwar Molecular Diversity 25, 1945-1961, 2021 | 1 | 2021 |
| Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy R Kumar, H Goel, R Solanki, L Rawat, S Tabasum, P Tanwar, S Pal, ... Medicine in Drug Discovery, 100195, 2024 | | 2024 |
| Whole exome sequencing identifies novel variants of PIK3CA and validation of hotspot mutation by droplet digital PCR in breast cancer among Indian population R Kumar, R Kumar, H Goel, S Kumar, SS Ningombam, I Haider, ... Cancer Cell International 23 (1), 236, 2023 | | 2023 |
| P163 Mutation profiling of NOTCH signaling pathway in primary breast cancer among Indian population P Tanwar, R Kumar The Breast 68, S78, 2023 | | 2023 |
